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Abstract: Allosteric modulation of catalysis is a common regulatory strategy of flux-controlling 
biosynthetic enzymes. The enzyme ATP phosphoribosyltransferase (ATPPRT) catalyses the 
first reaction in histidine biosynthesis, the magnesium-dependent condensation of ATP and 5-
phospho--D-ribosyl-1-pyrophosphate (PRPP) to generate N1-(5-phospho--D-ribosyl)-ATP 
(PRATP) and pyrophosphate (PPi). ATPPRT is allosterically inhibited by the final product of 
the pathway, histidine. Hetero-octameric ATPPRT consists of four catalytic subunits (HisGS) 
and four regulatory subunits (HisZ) engaged in intricate catalytic regulation. HisZ enhances 
HisGS catalysis in the absence of histidine while mediating allosteric inhibition in its presence. 
Here we report HisGS structures for the apoenzyme and complexes with substrates (PRPP, 
PRPP-ATP, PRPP-ADP), product (PRATP), and inhibitor (AMP), along with ATPPRT 
holoenzyme structures in complexes with substrates (PRPP, PRPP-ATP, PRPP-ADP) and 
product (PRATP). These ten crystal structures provide an atomic view of the catalytic cycle 
and allosteric activation of Psychrobacter arcticus ATPPRT. In both ternary complexes with 
PRPP-ATP, the adenine ring is found in an anticatalytic orientation, rotated 180° from the 
catalytic rotamer. Arg32 interacts with phosphate groups of ATP and PRPP, bringing the 
substrates in proximity for catalysis. The negative charge repulsion is further attenuated by a 
magnesium ion sandwiched between the - and -phosphate groups of both substrates. HisZ 
binding to form the hetero-octamer brings HisGS subunits closer together in a tighter dimer in 
the Michaelis complex, which poises Arg56 from the adjacent HisGS molecule for cross-
subunit stabilisation of the PPi leaving group at the transition state. The more electrostatically 
pre-organised active site of the holoenzyme likely minimises the reorganisation energy 
required to accommodate the transition state. This provides a structural basis for allosteric 
activation in which chemistry is accelerated by facilitating leaving group departure.   
Keywords: ATP phosphoribosyltransferase; allostery; HisG; HisZ; psychrophilic; catalytic 
activation; histidine biosynthesis 
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INTRODUCTION 
Adenosine 5ʹ-triphosphate phosphoribosyltransferase (ATPPRT) (EC 2.4.2.17) is a 
type-IV phosphoribosyltransferase (PRTase) in the PRTase superfamily.1-2 ATPPRT is 
responsible for the first and flux-controlling step in histidine biosynthesis, the nucleophilic 
attack of adenosine 5ʹ-triphosphate (ATP) N1 on 5-phospho--D-ribosyl-1-pyrophosphate 
(PRPP) C1 to generate N1-(5-phospho--D-ribosyl)-ATP (PRATP) and inorganic 
pyrophosphate (PPi)
3 (Scheme 1). The reaction is Mg2+-dependent and reversible, with the 
equilibrium strongly favouring reactants.4 ATPPRT is subjected to tight regulatory control in 
response to the metabolic status of the cell, being inhibited allosterically by histidine3, 5 and 
orthosterically by AMP and ADP.6 This enzyme is of interest as a potential drug target in some 
pathogenic bacteria,1, 7-9 whilst in plants it is implicated in Ni2+-tolerance,10-11 and it is a model 
system for the study of allosteric modulation of catalysis.7, 12-14 
 
Scheme 1. ATPPRT-catalysed nucleophilic substitution reaction. 
 The hisG gene encodes two forms of ATPPRT, a long-form of the protein (HisGL) 
found in plants, fungi, and most bacteria,13, 15 and a short-form (HisGS) present in archaea and 
some bacteria.16-17 HisGL is a homo-hexamer with each subunit consisting of two N-terminal 
domains containing the active site and a C-terminal allosteric domain responsible for histidine 
inhibition.1 HisGS consists of two catalytic domains structurally similar to HisGL’s, but lacks 
the C-terminal histidine-binding domain.16-17 HisGS is found in complex with HisZ, a 
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catalytically inactive regulatory protein, the product of the hisZ gene, a paralog of histidyl-
tRNA synthetase, forming the ATPPRT holoenzyme, a hetero-octamer where a HisZ tetramer 
is flanked by two HisGS dimers.
17-19 HisZ has a dual function: it allosterically enhances 
catalysis by HisGS, and it binds histidine and therefore mediates allosteric inhibition.
17, 20  
Synthetic biology efforts have attempted to harness the histidine biosynthetic pathway 
for industrial production of histidine in bacteria,21-23 as engineering of amino acid biosynthesis 
in microbes is a valuable tool for biocatalytic industrial production of these compounds.24-25 
An important challenge in exploitation is overcoming the strong inhibition of the pathway as 
histidine accumulates, with different strategies being employed towards that goal.22-23 The 
recent discovery that HisGS is catalytically active in the absence of HisZ, while being 
insensitive to histidine,15, 18 opens the possibility of utilising this enzyme as a starting point for 
biotechnological production of histidine. However, significant activity is lost in the absence of 
HisZ.15, 18 Elucidating the catalytic mechanism of HisGS could aid in rational engineering of a 
fully active HisGS for histidine production.    
 In the present work, we report ten crystal structures of the psychrophilic bacterium 
Psychrobacter arcticus HisGS (PaHisGS) and ATPPRT holoenzyme (PaATPPRT) bound to 
substrates, product and inhibitor. Two of the structures contain both PRPP and ATP in the 
active site, providing a rare glimpse of the pre-catalytic ternary complex. Analysis of the 
structures, along with site-directed mutagenesis, uncovers the basis for allosteric activation and 
allows a catalytic mechanism to be proposed. 
MATERIALS AND METHODS 
 Materials. ATP, PRPP, ribose, MgCl2, deuterium oxide (99.9 atom % deuterium), 
tricine, triethylamine, acetic acid, dithiothreitol (DTT), imidazole, glycerol, lysozyme, DNAse 
I, ampicillin, kanamycin, and chloramphenicol were purchased from Sigma-Aldrich. EDTA-
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free Cømplete protease inhibitor cocktail was from Roche. Isopropyl-β-D-1-
thiogalactopyranoside was purchased from Fisher Scientific. All other chemicals were 
purchased from readily available commercial sources, and all were used without further 
purification. PaHisGS, P. arcticus HisZ (PaHisZ), Mycobacterium tuberculosis 
pyrophosphatase (MtPPase), and tobacco etch virus protease were obtained as previously 
published.18 Escherichia coli PRPP synthetase (EcPRPPS) cloning, expression and 
purification, synthesis of D-ribose 5-phosphate, and synthesis and purification of PRATP are 
described in the Supporting Information. 
 Crystallisation of PaATPPRT. Crystals of PaATPPRT were obtained at 4 °C as 
previously described.18 To obtain structures of the complexes with various ligands (PRPP, 
PRPP + ATP, PRPP + ADP, PRATP), crystals were washed in buffer containing 10% 
polyethylene glycol (PEG) 3350, 0.1 M bicine pH 8.5, 50 mM MgCl2, 0.1 M KBr, 4% 1,6-
hexanediol, then transferred to a 1-L drop of this solution in which solid ligands soaked for 
30 s – 12 h. For data collection, crystals were transferred to a fresh drop of soaking solution 
substituted with 20% 2-methyl-2,4-pentanediol (MPD) for 10 s then flash-cooled in a stream 
of nitrogen gas at 100 K.  
Crystallisation of PaHisGS. Crystals were grown and handled at 4 °C as follows. 
PaHisGS in buffer containing 20 mM Tris HCl pH 8.0, 50 mM KCl, 10 mM MgCl2, and 2 mM 
DTT was concentrated to 10 mg mL-1. Crystallization screens were performed with 
commercially available and in-house stochastic screens. Hanging drops (150 nL protein 
solution and 150 nL of screen solution) were set up using an ArtRobbins Gryphon 
crystallization robot. One in-house condition gave small cube-shaped crystals with dimensions 
0.05 x 0.05 x 0.03 mm3. The precipitant solution contained 34% PEG 3350, 0.1 M MOPS pH 
6.5, 0.1 M K/Na tartrate. Crystals were reproduced by seeding into sitting and hanging drops 
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of protein with mother liquor containing 32% PEG 3350, 0.1 M MOPS pH 6.5, 0.1 M K/Na 
tartrate. Thin plate-like crystals grew in 3 weeks to a size suitable for data collection. To prepare 
ligand complexes (PRPP, PRPP + ATP, PRPP + ADP, PRATP, AMP), crystals were soaked 
in a drop containing 34% PEG 3350, 0.1 M bicine pH 8.5, 0.1 M K/Na tartrate, and 20 mM 
MgCl2 to which solid ligand had been added. Crystals were soaked for 3 – 24 h then 
cryoprotected with 20% MPD and frozen at 100 K for data collection. The apoenzyme and 
PRPP-ATP complex were also soaked in the presence of 22% glycerol with no differences 
observed in the final structures. 
X-ray data collection and processing. X-ray diffraction data were collected either in-
house as previously18 reported or at the Diamond Light Source, Oxfordshire, UK. Data were 
processed either in-house using iMosflm26 or the automated processing pipeline at Diamond 
with Xia227 integrated with XDS28. Data collection statistics are shown in Tables S1 and S2. 
The ligand-bound structures of PaATPPRT were solved by molecular replacement with 
MOLREP29 using 5M8H18 as search model. The apo and ligand-bound structures of PaHisGS 
were solved by molecular replacement using 5M8H18 chain E as search model. Structures were 
refined using cycles of model building with COOT30 and refinement with Refmac31. The 
electron density in the omit map showed the presence of ligands in each of PaHisGS active 
sites though the occupancy was not always 100%. In the apo-structure, some electron density 
was observed in the active site and modelled as tartrate, present in the soaking solution. 
Additional electron density was observed in PaATPPRT complexes with PRPP-ATP and with 
PRATP, and was modelled as Tris, the buffer in which the proteins were solubilised. ATP and 
ADP library files were generated with AceDRG.32 The coordinate and library files for PRATP 
were generated using PRODRG33. Refinement statistics are shown in Tables S1 and S2 for 
PaHisGS and PaATPPRT structures, respectively. All coordinates and structure factor files 
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have been deposited in the Protein Data Bank, and the corresponding PDB ID’s are shown in 
Tables S1 and S2.  
Determination of PaHisGS quaternary structure in solution. PaHisGS (3.3 mg) was 
subjected to size-exclusion chromatography (SEC) on a HiLoad 16/600 Superdex 200 pg 
column (GE healthcare) equilibrated with 20 mM HEPES pH 8.0. The sample was eluted in 
the same buffer at a flow rate of 1 mL min-1. The eluate was analyzed by multi-angle light 
scattering (MALS) detector DAWN HELEOS-II and refractive index detector Optilab T-rEX 
(Wyatt Techonologies). The elution peak, shown as changes in refractive index, was divided 
into 1-mL fractions in the ASTRA 6.1 software (Wyatt Techonologies) for calculations of 
molecule size in mean square radius (nm²) and molecular mass. 
Site-directed mutagenesis of PaHisGS. Replacement of arginine for alanine at position 
56 of PaHisGS was accomplished by the method of Liu and Naismith,
34 with primers 5ʹ- 
GCGCTAAGCTGATCTTCCCGACCAGCAACCCTAATGTG-3ʹ and 5ʹ- 
GGAAGATCAGCTTAGCGCTCGCTTCCGGATCTTCCAGC-3ʹ. Successful mutation was 
confirmed by DNA sequencing (Eurofins Genomics). R56A-PaHisGS was expressed and 
purified by the same protocol reported for wild-type (WT) PaHisGS.
18 Trypsin-digestion of 
R56A-PaHisGS followed by ESI-MS/MS analysis of the tryptic peptides further confirmed the 
presence of the mutation at position 56. Both WT- and R56A-PaHisGS at various 
concentrations were assayed for catalytic activity under initial-rate condition at 20 °C in the 
presence of 5.6 mM ATP and 2 mM PRPP and in the presence or absence of 17 M PaHisZ, 
along with other reaction components as previously described,18 in a Shimadzu UV-2600 
spectrophotometer. Measurements were carried out in duplicate. 
RESULTS AND DISCUSSION 
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 PRATP production. HPLC purification of PRATP is shown in Figure S1A. ESI-MS 
analysis showed the expected mass of 718.0 (Figure S1A inset), and the 31P-NMR spectrum 
(Figure S1B) displayed chemical shifts identical to those previously assigned.18          
Crystal structures of apo, PRPP-, PRPP-ATP-, and PRATP-bound PaHisGS. To gain 
insight into catalysis, PaHisGS crystal structures were solved in apo form and in complex with 
substrates and product. PaHisGS crystallised in I2 space group, and refinement statistics are 
summarised in Table S1. There is one monomer in the asymmetric unit, with a homodimer 
formed by crystallographic symmetry. Subunits in the homodimer interact in a head-to-tail 
arrangement (Figure S2A and B) almost identical to the arrangement found in the PaATPPRT 
structure.18 SEC-MALS analysis was used to establish the quaternary structure of PaHisGS in 
solution (Figure S3), resulting in a calculated molecular mass of ca. 48000, consistent with a 
homodimer (the monomer mass is 25215). This is the same oligomeric state reported for 
Lactococcus lactis HisGS.
15 Experimental density maps for all ligands are shown in Figure 
S2C. Overlaying C atoms among the four structures resulted in root-mean-square deviations 
(rmsd) of 0.26 Å, 0.22 Å, and 0.13 Å between PaHisGS and PaHisGS-PRPP, PaHisGS-PRPP 
and PaHisGS-PRPP-ATP, and PaHisGS-PRPP-ATP and PaHisGS-PRATP, respectively 
(Figure 1), reflecting minimal changes in overall subunit structure upon binding of substrates 
and product. 
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Figure 1. Ribbon diagram of the overlay of apo, PRPP-, PRPP-ATP-, and PRATP-bound 
PaHisGS subunits. Ligands are represented as stick models with carbon coloured as the 
corresponding ribbon, nitrogen in blue, oxygen in red, and phosphorus in orange. Magnesium 
ions are shown as light and dark grey spheres in the ATP-PRPP and PRATP structures, 
respectively. 
PaHisGS active site. Structures of PaHisGS-PRPP, PaHisGS-PRPP-ATP, and PaHisGS-
PRATP complexes show clear electron density for the ligands (Figure 2A-C) and reveal 
significant differences in active site interactions in comparison with other ATPPRT’s.8, 13, 19, 35-
36 Table S3 compiles key information on all structures of ATPPRT published to date, including 
the ones from this work. In the PaHisGS-PRPP structure, the substrate is anchored to the active 
site via several polar contacts among the 5-PO4
2- group and main-chain and side-chain atoms 
in the PRPP-binding loop (residues 179 to 183), and a hydrogen bond (H-bond) between the 
2-OH group and Asp176 side chain (Figure 2D). This H-bond prevents PRPP from obstructing 
the ATP-binding site, indicating a catalytically viable binary complex, similar to that seen in 
the L. lactis ATPPRT-PRPP structure,19 but contrary to the complex between PRPP and the 
Campylobacter jejuni ATPPRT structure.36 The PPi moiety of PRPP appears to be more 
flexible (B-factors between 68 and 83) than the 5-phosphoribosyl moiety (B-factors between 
23 and 45). The increased flexibility is consistent with the lack of specific contacts with the 
protein. Its only interaction is with a water molecule that also interacts with the 5-
phosphoribosyl (Figure 2D). In the L. lactis ATPPRT-PRPP, a serine residue side chain donates 
an H-bond to the -PO42- of the PPi moiety of PRPP.19 Mutations in conserved residues (T159A 
and T162A) in the PRPP-binding loop in L. lactis ATPPRT had detrimental effect on PRPP 
binding, but little influence on the catalytic rate.35 
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Despite numerous attempts involving both soaking and co-crystallisation, the PaHisGS-
ATP binary complex structure could not be obtained. On the other hand, the structure of the 
Michaelis complex with both PRPP and ATP bound to PaHisGS was readily attained (Figure 
2B), the first structure of an ATPPRT with both substrates in the active site. PRPP sits in a 
similar orientation in the ternary complex as it does in the binary (Figure 2D and E). Upon ATP 
binding, Arg32 side chain rotates ca. 180° around its C-C axis, breaking its H-bond with 
Asp179, to position its guanidinium group parallel to the adenine ring (Figure 2E). An Arg32-
Asp179 salt bridge in the PaHisGS-PRPP binary complex holds the active site open, otherwise 
Arg32 would prevent ATP binding (Figure 2E). A similar position of the equivalent arginine 
is found in the C. jejuni ATPPRT-ATP structure,13 and the residue is conserved in ATPPRT’s 
(Figure S4). Asp94 accepts H-bonds from the 2ʹ- and 3ʹ-OH groups, as in C. jejuni and M. 
tuberculosis ATPPRT complexes with ATP,8, 13 and Lys137 forms a salt bridge with the -
PO4
2-. ATP binding is further stabilised by a salt bridge between its -PO42- and Arg73 from 
the adjacent subunit (Figure 2E). The importance of this interaction may be negligible, though. 
The equivalent position in L. lactis ATPPRT is Lys50 which likely participates in a similar 
salt-bridge, but the K50A mutant has only moderate effect on ATP binding and catalysis.35 
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Figure 2. PaHisGS structures in complex with substrates and product. (A) PRPP, (B) PRPP-
ATP, and (C) PRATP omit maps at 1.0. Active-site close-up of PaHisGS bound to (D) PRPP, 
(E) PRPP-ATP, and (F) PRATP. In A-F, magnesium and waters are shown as green and red 
spheres, respectively, while ligands are represented as stick models with carbon in cyan, 
nitrogen in blue, oxygen in red, and phosphorus in orange. In D-F, the protein backbone is 
shown as ribbon diagram, with selected residues’ main and side chains shown as stick models 
coloured as the ligands except that carbon is in grey (same subunit) or magenta (adjacent 
subunit). Polar interactions are depicted by dashed lines. 
ATP and PRPP are brought into proximity for catalysis by salt bridges between Arg32 
and -PO42- groups of both substrates, and electrostatic repulsion among the negatively 
charged phosphate groups is attenuated by a Mg2+ ion sandwiched between the - and -PO42- 
groups of both PRPP and ATP, presumably the origin of the divalent metal requirement for 
catalysis. Except for Arg32, no other residue in the dimer interacts directly with the PPi moiety 
of PRPP, but its -PO42- accepts an intramolecular H-bond from the 2-OH group (Figure 2E). 
Given this scarcity of contacts with the enzyme, one might speculate that a second Mg2+ ion be 
necessary to stabilise the PPi leaving group at the transition state, since PPi’s departure as 
leaving group often involves a Mg2+ complex in enzymatic reactions,37 but its interaction with 
PRPP in the Michaelis complex might not be stable enough to be captured in the crystal 
structure. Absence of a putative second Mg2+ ion notwithstanding, catalysis would be 
prevented here owing to the orientation of the adenine, which places the nucleophile N1 away 
from PRPP C1. This orientation is held in place by a water-mediated interaction among 
Asp179, ATP 6-NH2 and PRPP 5-PO4
2- (Figure 2E). This anticatalytic ATP rotamer found in 
the structure is a possible reason a complex with both substrates could be trapped in the first 
place, since the catalytically active wild-type enzyme was used for crystallisation. Another 
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likely contributing reason is the reaction equilibrium, which strongly favours the reactants.4 
For the nucleophilic attack of ATP N1 on PRPP C1 to occur, the adenine must rotate ca. 180° 
around the N9-C1ʹ axis. In solution, thermal motion-driven conformational flexibility of the 
Michaelis complex would permit the stochastic sampling of reactive adenine orientations, but 
such flexibility is likely to be restrained in PaHisGS crystals. This hypothesis is further 
supported by the C. jejuni ATPPRT-ATP structure, where electron density for both rotamers 
was reported.13  
The structure of PaHisGS-PRATP binary complex shows electron density for the entire 
product (Figure 2C), as in the recent C. jejuni ATPPRT structure.36 Most interactions between 
enzyme and ligands found in the PaHisGS-PRPP and PaHisGS-PRPP-ATP structures are 
retained in the PaHisGS-PRATP complex, and the Mg
2+ ion is coordinated to the -, -, and -
PO4
2- of the product (Figure 2F). Overlay of the ligands in the three structures shows 
remarkably similar positions for the phosphoribosyl and triphosphoribosyl moieties and the 
Mg2+ ions in all structures (Figure 3). An interesting observation in the PaHisGS-PRATP 
structure is the 1.6-Å movement of one of the -NH groups of Arg32 towards the PRPP-
binding site, maintaining the guanidinium plane parallel to the adenine, but now donating an 
H-bond to the O4ʹʹ of PRATP (Figure 2F). This interaction might have mechanistic 
consequences, as it would further polarise the O4ʹʹ-C1ʹʹ (product numbering) bond, increasing 
C1ʹʹ electrophilicity, making it more prone to nucleophilic attack in an ANDN mechanism.38-39 
However, in a DN*AN
‡ mechanism,38 as proposed for other ATPPRT’s based on kinetic isotope 
effects,8 this interaction would be detrimental since it would destabilise the ribooxocarbenium 
ion intermediate. This raises the possibility that the PaHisGS-catalysed reaction proceeds via a 
different transition state. 
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Figure 3. Overlay of PaHisGS-bound ligands PRPP, PRPP-ATP, and PRATP structures. 
Magnesium is shown as sphere (green) while molecules are shown as stick with nitrogen in 
blue, oxygen in red, phosphorus in orange, and carbon in green (PRPP), cyan (PRPP-ATP), 
and magenta (PRATP). 
Crystal structures of AMP- and PRPP-ADP-bound PaHisGS. AMP and ADP are 
competitive inhibitors of HisGL ATPPRT’s with respect to both ATP and PRPP, providing an 
additional regulatory check-point that reflects the metabolic state of the cell.6, 35 This is 
explained structurally by the fact that the 5ʹ-phosphorybosyl and adenine moieties of AMP 
span the 5ʹ-phosphoribosyl and adenine binding sites of PRPP and ATP, respectively.1-2, 13 The 
PaHisGS-AMP structure (Figure 4A) shows the same overall binding mode for AMP as in 
other ATPPRT’s.1-2, 13 The 5ʹ-PO42- group makes similar interactions with the protein as the 
corresponding group in PRPP does. The adenine is anchored via H-bonds donated by its 6-NH2 
group to Ala113 -carbonyl oxygen and Arg32 guanidinium, and by an H-bond between its 
N7 and Arg32 guanidinium (Figure 4B). 
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Figure 4. PaHisGS structure in complex with AMP. (A) AMP omit map at 1.0. (B) Active-
site close-up of PaHisGS bound to AMP. In A and B, ligands are represented as stick models 
with carbon in cyan, nitrogen in blue, oxygen in red, and phosphorus in orange. In B, the protein 
backbone is shown as ribbon diagram, with selected residues’ main and side chains shown as 
stick models coloured as the ligands except that carbon is in grey. Polar interactions are 
depicted by dashed lines. 
Crystals of the PaHisGS-ADP binary complex could not be obtained, as was the case 
with ATP, but the structure of the PaHisGS-PRPP-ADP ternary complex was readily 
determined (Figure 5A). ADP sits in the active site in same way ATP does, and almost all 
interactions present in the PaHisGS-PRPP-ATP complex (Figure 2E) are preserved in the 
PaHisGS-PRPP-ADP structure, including the Mg
2+ ion binding between the - and -PO42- 
groups of both ligands (Figure 5B). An exception is the salt bridge with Arg73 of the adjacent 
subunit. This residue is found in the same position as in the ATP-PRPP complex, but it is too 
far away to reach the -PO42- of ADP. Overlay of the ligands in these two structures shows 
hardly any difference in binding (Figure 5C). This suggests that ADP is not an inhibitor of 
PaHisGS, but may be an alternative substrate. 
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Figure 5. Structure of PaHisGS-PRPP-ADP complex. (A) PRPP-ADP omit map at 1.0. (B) 
Active-site close-up of PaHisGS bound to PRPP-ADP. (C) Overlay of PRPP-ATP and PRPP-
ADP structures. In A and B, magnesium and waters are shown as green and red spheres, 
respectively, while ligands are represented as stick models with carbon in cyan, nitrogen in 
blue, oxygen in red, and phosphorus in orange. The protein backbone is shown as ribbon 
diagram, with selected residues’ main and side chains shown as stick models coloured as the 
ligands except that carbon is in grey. Polar interactions are depicted by dashed lines. In C, 
colours are the same as in A and B, except that carbon is in cyan for PRPP-ATP and grey for 
PRPP-ADP.  
  Crystal structures of PRPP-, PRPP-ATP-, PRATP-, and PRPP-ADP-bound 
PaATPPRT. It is well known that HisGS catalysis is activated by HisZ,
15, 18, 20 but the 
mechanism of activation is still elusive. We have recently published the structure of 
PaATPPRT apoenzyme,18 and to uncover structural features that could account for activation 
and to glean further information on catalysis, PaATPPRT structures were solved in complex 
with PRPP, PRPP-ATP, PRATP and PRPP-ADP, and refinement statistics are summarised in 
Table S2. PaATPPRT-PRPP crystallised in the P21 space group with one full hetero-octamer 
in the asymmetric unit (Figure 6A), as found for apo PaATPPRT.18 The remaining structures 
were solved in the C2 space group and had a PaHisGS dimer and a PaHisZ dimer in the 
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asymmetric unit (Figure 6B), with the hetero-octamer formed by crystallographic symmetry. 
Experimental and refined electron density maps for all ligands are shown in Figure S5. The 
position of the Mg2+ ion in the PRATP structure could not be unambiguously assigned.  
 
Figure 6. Ribbon diagrams of PaATPPRT structures with bound (A) PRPP and (B) PRPP-
ATP. PaHisGS subunits are shown in grey and magenta, while PaHisZ subunits are shown in 
yellow and brown. Magnesium is shown as sphere (green) while substrates are shown as stick 
with nitrogen in blue, oxygen in red, phosphorus in orange, and carbon in cyan. 
PaATPPRT active site. Most interactions between protein and ligands present in the 
PaHisGS structures are retained in the corresponding PaATPPRT, with some additional ones 
(Figure 7). In the PRPP- and PRPP-ATP-bound structures, Glu163 accepts an H-bond from the 
3-OH group, which may help position PRPP for catalysis (Figure 7A and B). The adjacent 
PaHisGS subunit contributes two residues to the active site, Arg56 and Arg73. The side chain 
of Arg73 anchors the -PO42- in the ternary complex, as seen in the PaHisGS structure, and its 
position changes little from the substrate and product binary complexes. The equivalent residue 
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is conserved in T. maritima ATPPRT,17 and is replaced by a lysine in the L. lactis enzyme.20 
Most revealing in all three structures is the position of Arg56. This residue is in the middle of 
a flexible loop extending residues Ala44-Val67, and its guanidium group lies ca. 12 Å away 
from the PRPP -PO42- in the binary complex. Upon ATP binding, Arg56 side chain moves 
towards the active site to form a salt bridge with the PPi moiety of PRPP (Figure 7B). This 
interaction is responsible for leaving group stabilisation during the transition state, possibly 
aided by a putative second Mg2+ ion as PPi likely departs the enzyme as a Mg
2+ complex. In 
the PRATP complex (Figure 7C), Arg56 is more than 6 Å away from its position in the ternary 
complex. Amino acid multiple sequence alignment of HisGS’s reveals the high degree of 
conservation of this residue (Figure S4), lending support to its role in catalysis. 
  
Figure 7. Active-site close-up of PaATPPRT bound to (A) PRPP, (B) PRPP-ATP, and (C) 
PRATP, compared with the corresponding structures in PaHisGS (D – F). Magnesium is shown 
as green sphere while ligands are represented as stick models with carbon in cyan, nitrogen in 
blue, oxygen in red, and phosphorus in orange. The protein backbone is shown as ribbon 
diagram, with selected residues’ main and side chains shown as stick models coloured as the 
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ligands except that carbon is in grey. The side chains of two Arg residues contributed by the 
adjacent subunit are shown as stick models coloured as the ligands except that carbon is in 
magenta. Only residues whose interactions with ligands are absent in the PaHisGS structures 
(D – F) are labelled in the PaATPPRT structures (A – C). Polar interactions are depicted by 
dashed lines. 
Contacts in the PaATPPRT-PRPP-ADP structure (Figure S6) are similar to those in 
PaHisGS. This is consistent with ADP acting as a substrate for this enzyme, contrary to its 
inhibitory role in HisGL ATPPRT’s.6 The adenine ring in the two PaATPPRT Michaelis 
complexes is found in the same anticatalytic orientation seen in the corresponding PaHisGS. 
Structural basis of allosteric activation. PaHisZ has little effect on the overall structures 
of PaHisGS apoenzyme and PRPP- and PRATP-bound binary complexes, as evidenced by 
superposition of C atoms of these forms of PaHisGS dimers onto their counterparts in 
PaATPPRT (Figure S7), resulting in rmsd’s of 0.41 Å, 0.47 Å, and 0.40 Å, respectively. 
However, overlay of C atoms of PaHisGS dimers in complex with PRPP-ATP with and 
without PaHisZ show the catalytic subunits moving closer to one another upon binding of the 
regulatory protein (Figure 8A), yielding an rmsd of 1.49 Å. This affects cross dimer contacts 
of specific side chains with substrates. While Arg73 position is very similar in PaHisGS and 
PaATPPRT and maintains is interaction with the -PO42- of the adjacent subunit, Arg56 
position changes drastically in the two enzymes, and only forms a salt bridge with the PPi 
moiety of PRPP in the PaATPPRT structure (Figure 8B). In nonactivated PaHisGS ternary 
complex, Arg56 side chain lies over 7 Å away from the PPi moiety of PRPP. Given that Arg56 
is the most likely candidate to stabilise the leaving group in the chemical step, catalysis is 
favoured in PaATPPRT owing to its ability to respond more readily to ternary-complex 
formation than PaHisGS. A more electrostatically pre-organised active site in the holoenzyme 
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incurs in lower reorganisation energy penalty as the Michaelis complex moves towards the 
transition state where a highly charged leaving group must be stabilised.40-41 It should be 
pointed out that even though our hypothesis for the structural features underlying allosteric 
activation is based on static snapshots, it is entirely compatible with a contemporary view of 
allostery and catalysis that reflects the dynamic fluctuation of the enzyme across the 
conformational space,12, 42-43 with the catalytically favourable position of Arg56 stochastically 
sampled more often in PaATPPRT than in PaHisGS. 
    
Figure 8. PaHisZ-induced active site pre-organisation in PaATPPRT. (A) Overlay of PRPP-
ATP-bound PaATPPRT (magenta) and PaHisGS (grey) dimers. (B) Active site close-up of the 
superimposed dimers showing cross-subunit contacts. Magnesium ions are shown as green 
spheres while substrates, Arg56 and Arg73 side chains are represented as stick models with 
nitrogen in blue, oxygen in red, phosphorus in orange, and carbon in magenta (PaATPPRT) 
and grey (PaHisGS). Polar interactions are depicted by dashed lines. 
 Effect of Arg56Ala mutation on catalysis. The crystal structures suggest that Arg56 
plays a key role in catalysis by stabilising the leaving group. To test that hypothesis, the 
enzymatic activities of R56A-PaHisGS and WT-PaHisGS were evaluated with and without 
PaHisZ (Figure S8). Upon correction for enzyme concentration, in the absence of PaHisZ, 
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R56A-PaHisGS reaction rate is 86-fold lower than that of WT-PaHisGS, evidencing a crucial 
role in catalysis for Arg56. Interestingly, in the presence of PaHisZ, R56A-PaHisGS reaction 
rate is 6-fold lower than that of the WT-PaHisGS (Figure S8B). This suggests that, while Arg56 
still plays an important role in PaATPPRT catalysis, the activated enzyme promotes sampling 
of different conformations that potentially positions another residue to stabilise the leaving 
group PPi at the transition state, albeit less efficiently, in the absence of Arg56, partially 
offsetting the effect of the mutation. 
 Catalytic mechanism. The extensive structural work carried out here represents the 
most complete set of structures for an ATPPRT, allowing a catalytic mechanism to be proposed 
for the PaATPPRT-catalysed reaction (Scheme 2). Nucleophilic attack likely occurs from a 
resonance state of adenine in which N1 is negatively charged due to electron transfer from N6, 
an idea supported by density-functional theory calculations that indicate this natural resonance 
state represents 6.64% of the distribution of adenine resonance structures.44 This resonance 
structure might be further stabilised by the proximity of N1 to the positively charged 
guanidinium group of Arg32. None of the crystal structures reported here showed a strong base 
near 6-NH2 group, which suggests that deprotonation may occur only after N1-C1 bond 
formation and leaving group departure. The PRATP 6-NH2
+ group has a pKa of 8.5,
45 several 
log units lower than that of the 6-NH2 group of ATP.
46 The PPi leaving group is stabilised at 
the transition state by H-bonds with Arg56, and probably departs the enzyme in a complex with 
a second Mg2+ ion.  
A different kinetic mechanism may also be inferred from the set of structures presented 
here. HisGL ATPPRT’s follow an ordered mechanism in which ATP is the first substrate to 
bind to, and PRATP the last product to dissociate from, the enzyme,47 a proposal supported by 
crystal structures of HisGL showing catalytically viable complexes with either ATP or 
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PRATP,8, 36, 48-49 but a dead-end binary complex with PPRP.36 The structures of the various 
complexes of PaHisGS and PaATPPRT suggest that HisGS ATPPRT’s proceed by the same 
order of product dissociation, but the opposite order of substrate binding, with PRPP binding 
to the free enzyme, followed ATP binding. This is corroborated by the structure of L. lactis 
ATPPRT-PRPP binary complex.19 
 
Scheme 2. Proposed catalytic mechanism for the PaATPPRT reaction. 
Allosteric control of enzyme activity is a ubiquitous feature of metabolic and signalling 
pathways, and harnessing this control generates opportunities in drug design and 
biotechnology.7, 12, 50 In large multiprotein complexes of key biosynthetic enzymes, elucidation 
of allosteric activation mechanisms can inform engineering of small subunits that capture full 
biosynthetic potential while reducing the protein synthesis burden of host cells.51 Short-form 
ATPPRT’s can be used in the industrial production of histidine as the catalytic activity of HisGS 
subunit is not subjected to inhibition by histidine. However, activity in the absence of HisZ is 
reduced.15, 18 The work reported here provides a detailed structural picture of the interactions 
of activated and nonactivated PaHisGS with substrates and products. These structures can serve 
as a framework for rational engineering of PaHisGS towards increasing its catalytic activity. 
For instance, a combination of in silico mutations in PaHisGS dimer interface and molecular 
dynamics simulations of the mutant PaHisGS in complex with PRPP-ATP could be used to 
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identify variants which favour interaction between Arg56 and the PPi leaving group, 
recapitulating the allosteric activation exerted by PaHisZ. Promising candidate PaHisGS 
mutants could then be produced and tested for improved catalytic properties.     
SUPPORTING INFORMATION AVAILABLE 
Materials and methods for the cloning, expression and purification of EcPRPPS, 
synthesis of D-ribose 5-phosphate, and synthesis and purification of PRATP, Figures S1 – S8, 
and Tables S1 – S3. This material is available free of charge via the internet at 
http://pubs.acs.org. 
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-D-ribosyl-1-pyrophosphate; PRATP, N1-(5-phospho--D-ribosyl)-ATP; PPi, inorganic 
pyrophosphate; HisGL, long-form HisG; HisGS, short-form HisG; PaHisGS, P. arcticus HisGS; 
PaATPPRT, P. arcticus ATPPRT; PaHisZ, P. arcticus HisZ; DTT, dithiothreitol; MtPPase, 
Mycobacterium tuberculosis inorganic pyrophosphatase; EcPRPPS, E. coli PRPP synthetase; 
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light scattering; LC-MS, liquid chromatography-mass spectrometry; ESI-MS, electrospray 
ionisation mass spectrometry; rmsd, root-mean square deviation; H-bond, hydrogen bond. 
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